0001543836-22-000001.txt : 20220506
0001543836-22-000001.hdr.sgml : 20220506
20220506170858
ACCESSION NUMBER: 0001543836-22-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220506
DATE AS OF CHANGE: 20220506
EFFECTIVENESS DATE: 20220506
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSFORMATIVEMED INC.
CENTRAL INDEX KEY: 0001543836
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-444878
FILM NUMBER: 22902281
BUSINESS ADDRESS:
STREET 1: 219 FIRST AVE SOUTH
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98104
BUSINESS PHONE: 206-696-3287
MAIL ADDRESS:
STREET 1: 219 FIRST AVE SOUTH
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98104
D
1
primary_doc.xml
X0708
D
LIVE
0001543836
TRANSFORMATIVEMED INC.
3131 Elliot Ave
SUITE 600
SEATTLE
WA
WASHINGTON
98121
206-457-8642
DELAWARE
None
None
Corporation
true
David
Stone
c/o TransformativeMed Inc
3131 Elliott Ave, Suite 600
Seattle
WA
WASHINGTON
98121
Executive Officer
Director
Erik
Van Eaton
c/o TransformativeMed Inc.
3131 Elliott Ave, Suite 600
Seattle
WA
WASHINGTON
98121
Executive Officer
Daniel
Rosen
c/o TransformativeMed Inc.
3131 Elliott Ave, Suite 600
Seattle
WA
WASHINGTON
98121
Director
Nathan
Bays
c/o TransformativeMed Inc.
3131 Elliott Ave, Suite 600
Seattle
WA
WASHINGTON
98121
Director
Shawn
DeWane
c/o TransformativeMed Inc.
3131 Elliott Ave, Suite 600
Seattle
WA
WASHINGTON
98121
Executive Officer
Director
Joel
Mezistrano
c/o TransformativeMed Inc.
3131 Elliott Ave, Suite 600
Seattle
WA
WASHINGTON
98121
Director
Other Technology
Decline to Disclose
- 06b
false
2022-04-18
false
true
false
0
1200000
1200000
0
false
33
0
0
0
false
TRANSFORMATIVEMED INC.
/s/Shawn DeWane
Shawn DeWane
Chief Executive Officer
2022-05-06